English

pharmaceuticals

Health news

EU health chief to probe effects of Trump’s drug pricing push

ADVERTISEMENT

ADVERTISEMENT

Health news

Experimental oral drug lowers ‘bad’ cholesterol by 60%, study finds

A new pill in the final phase of clinical trials cuts harmful cholesterol by 60% in high-risk patients.

Health news

Why weight loss drugs aren't Denmark's trump card in Greenland dispute

Novo Nordisk, the Danish manufacturer of weight-loss drugs Ozempic and Wegovy, has a large market share in the US. But it's not enough to put pressure on US President Donald Trump's administration during Greenland talks, experts say.

Health news

EU unveils new pharma package to boost industry

The European Union has agreed on new pharmaceutical rules introducing new incentives to boost the pharmaceutical industry amid accessibility concerns.

Business

UK and US agree on zero-tariff pharma deal after months of tensions

London and Washington have found a compromise that would avoid US tariffs on British medicines — but only after the UK agreed to pay more for cutting-edge drugs.

ADVERTISEMENT

Business

Pharma market shake-up: Bayer jumps, Novo Nordisk sinks 10%

Shares of Danish pharmaceutical giant Novo Nordisk fell sharply after its Alzheimer's drug failed to slow progression of the disease in a trial. Meanwhile, Germany's Bayer said their stroke-prevention drug showed positive results, pushing the share price through the roof.

Healthcare

New malaria treatment could fight growing threat of drug resistance

Drugmaker Novartis said it will move quickly to ask regulators to approve the new medicine.

Business

Markets exhale as Novo Nordisk withdraws from Metsera bidding war

Equity markets delivered a mixed response after Pfizer won the bidding war for anti-obesity drugmaker Metsera, as Metsera’s shares slipped but Novo Nordisk’s stock rose on news it was bowing out of the race.

Germany

This is how dependent Germany is on Chinese medicines

Germany sold more than 15 million tonnes of pharmaceutical products to China in 2024, while China sold more than 33 million tonnes to Germany.

Business

Pfizer agrees to lower prescription drug costs for Medicaid

Under the deal, New York-based Pfizer will charge most-favoured-nation pricing to Medicaid and guarantee that pricing on newly launched drugs, Trump said. That involves matching the lowest price offered in other developed nations.

Business

Big Pharma’s retreat: Is NHS pricing behind investor pullbacks?

Multinational pharmaceutical firms are pulling pack or pausing investments in the UK, blaming a lack of competitive drug pricing.

Markets

AstraZeneca to list shares in New York, without leaving the UK

Amid concerns it might leave the UK, the pharma giant reaffirmed its commitment to the country, keeping its headquarters, primary listing, and tax base there.

Europe in Motion

EU high-tech exports recover: What's the most profitable sector?

Pharma has become the EU's most valuable high-tech export, driving the bloc's first trade surplus in years. But can it survive the impact of US tariffs?

Economy

Trump to put import taxes on pharma, home furnishings, heavy trucks

While Trump did not provide a legal justification for the tariffs, he appeared to stretch the bounds of his role as commander-in-chief by stating on Truth Social that the taxes on imported kitchen cabinets and sofas were needed “for national security and other reasons".

Europe News

EU countries agree to dilute rules on water quality standards

Green groups regret lax environmental standards on pharmaceuticals, voluntary monitoring and late compliance dates from the political agreement reached on the Water Framework Directive’s revision.

Health news

Cheaper HIV prevention jab to launch in lower income countries in 2027

The twice-yearly drug has been hailed as a medical breakthrough that could change the course of the HIV epidemic.

Economy

The Ozempic ripple: When a single jab moves an entire market

As GLP-1 use spreads, grocers and restaurants see lighter baskets, airlines predict fuel savings and health systems eye lower costs—while Denmark sees a clipped GDP.